rhodioloside has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Huang, L; Kang, X; Li, R; Li, T; Sun, X; Yang, Q; Yang, R; Zhang, W | 1 |
Chen, J; Chen, L; He, H; Wang, S; Zhang, W; Zhang, X | 1 |
Feng, D; Huang, L; Lai, J; Lu, F; Nie, T; Tao, K; Wang, B; Yang, Q; Zhang, W | 1 |
Chen, J; Kang, X; Li, X; Liang, Q; Sun, X; Tao, L; Ye, X | 1 |
4 other study(ies) available for rhodioloside and Autosomal Dominant Juvenile Parkinson Disease
Article | Year |
---|---|
Salidroside protects dopaminergic neurons by regulating the mitochondrial MEF2D-ND6 pathway in the MPTP/MPP
Topics: Animals; Cell Survival; Dopaminergic Neurons; Glucosides; Male; MEF2 Transcription Factors; Mice; Mice, Inbred C57BL; Mitochondria; NADH Dehydrogenase; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Phenols; Signal Transduction | 2020 |
Protective effects of salidroside in the MPTP/MPP(+)-induced model of Parkinson's disease through ROS-NO-related mitochondrion pathway.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Survival; Dose-Response Relationship, Drug; Glucosides; Male; Mice; Mice, Inbred C57BL; Mitochondria; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Parkinsonian Disorders; Phenols; Reactive Oxygen Species; Signal Transduction | 2015 |
Salidroside Protects Against 6-Hydroxydopamine-Induced Cytotoxicity by Attenuating ER Stress.
Topics: Adrenergic Agents; Animals; Apoptosis; Blotting, Western; Cell Line; Cell Survival; Dopaminergic Neurons; Endoplasmic Reticulum Stress; Glucosides; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Phenols; Rats; Rats, Sprague-Dawley | 2016 |
Salidroside protects against MPP(+)-induced apoptosis in PC12 cells by inhibiting the NO pathway.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Glucosides; Membrane Potential, Mitochondrial; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Oxidative Stress; Parkinsonian Disorders; PC12 Cells; Phenols; Rats; Reactive Oxygen Species; Signal Transduction | 2011 |